Summary of findings ‐ Inhaled mannitol vs dornase alfa
FEV1 % predicted · children and young adults with CF
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
64 questions · 66 findings · 4 reviews
No studies found 19 · 28.8%GRADE not reported 0 · 0%Very low 15 · 22.7%Low 27 · 40.9%Moderate 3 · 4.5%High 2 · 3%
Summary of findings ‐ Inhaled mannitol vs dornase alfa
FVC · children and young adults with CF
It is very uncertain whether summary of findings ‐ Inhaled mannitol changes lung function: FVC mL (percentage change from baseline) compared with dornase alfa (very low certainty).
1 finding from 1 review
- MD 0.14231 participantsVery low
Summary of findings ‐ Inhaled mannitol vs dornase alfa
Lung function: FEF25‐75 mL/s (percentage change from baseline) · children and young adults with CF
It is very uncertain whether summary of findings ‐ Inhaled mannitol changes lung function: FEF25-75 mL/s (percentage change from baseline) compared with dornase alfa (very low certainty).
1 finding from 1 review
- no estimate extracted231 participantsVery low
Summary of findings ‐ Inhaled mannitol vs dornase alfa
Adverse events relating to treatment Scale: mild, moderate, severe and total · children and young adults with CF
1 finding from 1 review
- no estimate extracted231 participantsVery low